COMPARISON OF THE HISTOPATHOLOGICAL AND CLINICAL PROGNOSTIC PARAMETERS IN HUMAN EPİDERMAL GROWTH FAKTÖR 2 (HER2 2) 2+/AMPLIFIED AND HER2 2+/NON-AMPLIFIED GROUPS OF THE CASES WITH INVASIVE BREAST CARCINOMA